U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
113941113941Intraperitoneal Bortezomib and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerActive, not recruitingNo Results AvailableFallopian Tube Clear Cell Adenocarcinoma|Fallopian Tube Endometrioid Adenocarcinoma|Fallopian Tube Mucinous Adenocarcinoma|Fallopian Tube Serous Adenocarcinoma|Fallopian Tube Transitional Cell Carcinoma|Malignant Ovarian Mixed Epithelial Tumor|Ovarian BreDrug: Bortezomib|Drug: Carboplatin|Other: Laboratory Biomarker Analysis|Other: Pharmacological Studyhttps://ClinicalTrials.gov/show/NCT01074411
113942113942Biomarkers in Predicting Response in Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Treated on GOG-0172 or GOG-0182Not yet recruitingNo Results AvailableFallopian Tube Cancer|Ovarian Cancer|Peritoneal Cavity CancerGenetic: gene expression analysis|Genetic: polymorphism analysis|Genetic: protein expression analysis|Other: immunohistochemistry staining method|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT01074398
113943113943Dignity Therapy in mCRC to Increase Peaceful Awareness & Impact Goals of Care Decision-MakingCompletedNo Results AvailableStage IV Colorectal CancerBehavioral: Dignity Therapyhttps://ClinicalTrials.gov/show/NCT01074385
113944113944Ascending Dose Study of the Safety and Tolerability of REGN727 (SAR236553) in Healthy VolunteersCompletedNo Results AvailableHealthy VolunteersDrug: REGN727|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01074372
113945113945Safety and Efficacy Study of A0001 in Patients With the A3243G Mitochondrial DNA Point MutationTerminatedNo Results AvailableNeuromuscular DiseaseDrug: A0001 (alpha-tocopherolquinone)|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01074359
113946113946Tolerability of Rebif® (Interferon-beta 1-A) Therapy in Korean Patients With Multiple SclerosisCompletedNo Results AvailableMultiple SclerosisDrug: Interferon-β-1ahttps://ClinicalTrials.gov/show/NCT01074346
113947113947An Observational Study of Erbitux® in Patients With Metastatic Colorectal Cancer (mCRC) Refractory to Irinotecan-containing TreatmentTerminatedNo Results AvailableColorectal NeoplasmDrug: Cetuximabhttps://ClinicalTrials.gov/show/NCT01074333
113948113948Measuring Musculoskeletal Symptoms in Patients Receiving Aromatase InhibitorsCompletedNo Results AvailableBreast CancerOther: Otherhttps://ClinicalTrials.gov/show/NCT01074320
113949113949A Prospective, Open-labeled, Multi-centric Trial in Subjects With Systolic Heart Failure to Evaluate Bisoprolol Treatment for the Effects on Surrogate Markers of Heart Failure in KoreaCompletedHas ResultsHeart Failure, CongestiveDrug: Low Dose Bisoprolol|Drug: High Dose Bisoprololhttps://ClinicalTrials.gov/show/NCT01074307
113950113950Study of the Safety and Efficacy of OPC-34712 as a Complementary Therapy in the Treatment of Adult Attention Deficit/Hyperactivity DisorderCompletedNo Results AvailableAttention Deficit Hyperactivity DisorderDrug: OPDC-34712 + Stimulant Therapy|Drug: Placebo + Stimulant Therapyhttps://ClinicalTrials.gov/show/NCT01074294
113951113951An Observational Study to Examine the Patients With Isolated Systolic Hypertonia (ISH) Under Therapy With Eneas® (NIS ENEAS ISH)CompletedNo Results AvailableHypertensionDrug: Enalapril maleate (10 mg) + nitrendipine (20 mg)https://ClinicalTrials.gov/show/NCT01074281
113952113952Comparison of NN1250 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspart in Type 1 DiabetesCompletedNo Results AvailableDiabetes|Diabetes Mellitus, Type 1Drug: insulin degludec|Drug: insulin detemir|Drug: insulin asparthttps://ClinicalTrials.gov/show/NCT01074268
113953113953Re-examination Study of EMEND (Aprepitant) (MK-0869-184)CompletedHas ResultsChemotherapy-induced Nausea and VomitingDrug: EMENDhttps://ClinicalTrials.gov/show/NCT01074255
113954113954ROTATEQ Reexamination Study (V260-037)CompletedHas ResultsGastroenteritis Rotavirushttps://ClinicalTrials.gov/show/NCT01074242
113955113955Transversus Abdominis Plane (TAP) Block Laparoscopic HysterectomyCompletedHas ResultsPostoperative PainDrug: Placebo|Drug: Drug .5% Ropivacaine|Drug: 20 cc of 0.25% ropivacainehttps://ClinicalTrials.gov/show/NCT01074229
113956113956Vitamin D Levels in Stage IV Colorectal Cancer PatientsCompletedNo Results AvailableColorectal CancerDrug: vitamin D repletion with Cholecalciferol (vitamin D3 50,000 International Units)https://ClinicalTrials.gov/show/NCT01074216
113957113957A Pilot Study to Examine the Role of Nitazoxanide to Prevent Recurrence of Hepatitis C After TransplantationCompletedNo Results AvailableHepatitis C RecurrenceDrug: Nitazoxanidehttps://ClinicalTrials.gov/show/NCT01074203
113958113958The Effect of Neuraxial Analgesia on Maternal BreastfeedingRecruitingNo Results AvailablePain|BreastfeedingDrug: Group 1|Drug: Group 2|Drug: Group 3https://ClinicalTrials.gov/show/NCT01074190
113959113959Understanding Mechanisms of Acquired Resistance to BIBW2992Active, not recruitingNo Results AvailableNon-small Cell Lung Cancer|EGFR MutationsDrug: BIBW 2992https://ClinicalTrials.gov/show/NCT01074177
113960113960Acupressure in Pruritus for Atopic DermatitisCompletedHas ResultsAtopic DermatitisOther: Standard-of-care treatment for AD|Device: Accu-patch pellethttps://ClinicalTrials.gov/show/NCT01074164
113961113961The Cymbalta Pregnancy RegistryRecruitingNo Results AvailablePregnancyDrug: duloxetinehttps://ClinicalTrials.gov/show/NCT01074151
113962113962A Safety and Efficacy Study of KX2-391 in Patients With Bone-Metastatic, Castration-Resistant Prostate Cancer Who Have Not Received Prior ChemotherapyCompletedNo Results AvailableBone-Metastatic, Castration-Resistant Prostate CancerDrug: KX2-391https://ClinicalTrials.gov/show/NCT01074138
113963113963A 4-Week Dose-Ranging and Efficacy Trial of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal DiseaseCompletedHas ResultsHyperphosphatemia|End-Stage Renal DiseaseDrug: ferric citratehttps://ClinicalTrials.gov/show/NCT01074125
113964113964Keller Prehospital Ultrasound StudyNot yet recruitingNo Results AvailableUltrasonography|Multiple Trauma|Kidney Calculi|Aortic Aneurysm, Abdominal|Pregnancy|Catheterization, VenousDevice: EFAST exam|Device: Pelvic Ultrasound|Procedure: Ultrasound Guided Vascular Access|Device: Focused Ultrasound Scan|Device: Cardiac Ultrasoundhttps://ClinicalTrials.gov/show/NCT01074112
113965113965Feasibility Study of BMAC Enhanced CABGTerminatedNo Results AvailableCongestive Heart FailureBiological: BMAC|Procedure: CABG onlyhttps://ClinicalTrials.gov/show/NCT01074099
113966113966Phase I Study in RAD 001 Patients With Relapse AMLCompletedNo Results AvailableAMLDrug: RAD 001https://ClinicalTrials.gov/show/NCT01074086
113967113967Lithium Drug-Drug Interaction Study With Lurasidone HClCompletedNo Results AvailableSchizophreniaDrug: Lurasidone HClhttps://ClinicalTrials.gov/show/NCT01074073
113968113968Plerixafor and Filgrastim Following Cyclophosphamide for Stem Cell Mobilization in Patients With Multiple MyelomaCompletedNo Results AvailableRefractory Multiple Myeloma|Stage I Multiple Myeloma|Stage II Multiple Myeloma|Stage III Multiple MyelomaDrug: plerixafor|Biological: filgrastim|Drug: cyclophosphamide|Procedure: autologous hematopoietic stem cell transplantation|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT01074060
113969113969Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)Active, not recruitingHas ResultsAcute Myeloid LeukemiaDrug: Azacitidine|Drug: Conventional Care Regimenhttps://ClinicalTrials.gov/show/NCT01074047
113970113970REASSURE AV RegistryCompletedNo Results AvailableSudden Cardiac Death|BradycardiaDevice: B301 ASSURE Devicehttps://ClinicalTrials.gov/show/NCT01074034

* Görseller ve İçerik tekif hakkına sahip olabilir